United States (US) Plasma Protease C1-Inhibitor Market (2025-2031) | Industry, Trends, Outlook, Segmentation, Competitive Landscape, Value, Companies, Growth, Forecast, Share, Analysis, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Plasma Protease C1-Inhibitor Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Plasma Protease C1-Inhibitor Market - Industry Life Cycle

3.4 United States (US) Plasma Protease C1-Inhibitor Market - Porter's Five Forces

3.5 United States (US) Plasma Protease C1-Inhibitor Market Revenues & Volume Share, By End-user, 2021 & 2031F

3.6 United States (US) Plasma Protease C1-Inhibitor Market Revenues & Volume Share, By Product, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of hereditary angioedema (HAE) in the US

4.2.2 Growing awareness and diagnosis of HAE among healthcare professionals and patients

4.2.3 Advancements in biotechnology leading to improved plasma protease C1-inhibitor products

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval and commercialization of plasma protease C1-inhibitor products

4.3.2 High cost of treatment leading to limited access for some patients

6.1 United States (US) Plasma Protease C1-Inhibitor Market, By End-user

6.1.1 Overview and Analysis

6.1.2 United States (US) Plasma Protease C1-Inhibitor Market Revenues & Volume, By End-user, 2021- 2031F

6.1.3 United States (US) Plasma Protease C1-Inhibitor Market Revenues & Volume, By Hospital pharmacy, 2021- 2031F

6.1.4 United States (US) Plasma Protease C1-Inhibitor Market Revenues & Volume, By Retail pharmacy, 2021- 2031F

6.1.5 United States (US) Plasma Protease C1-Inhibitor Market Revenues & Volume, By Online pharmacy, 2021- 2031F

6.2 United States (US) Plasma Protease C1-Inhibitor Market, By Product

6.2.1 Overview and Analysis

6.2.2 United States (US) Plasma Protease C1-Inhibitor Market Revenues & Volume, By Lyophilized, 2021- 2031F

6.2.3 United States (US) Plasma Protease C1-Inhibitor Market Revenues & Volume, By Injectable, 2021- 2031F

7.1 United States (US) Plasma Protease C1-Inhibitor Market Export to Major Countries

7.2 United States (US) Plasma Protease C1-Inhibitor Market Imports from Major Countries

8.1 Patient adherence rate to plasma protease C1-inhibitor therapy

8.2 Number of clinical trials evaluating new plasma protease C1-inhibitor products

8.3 Rate of adoption of plasma protease C1-inhibitor therapy by healthcare providers

8.4 Average time to market for new plasma protease C1-inhibitor products

8.5 Patient satisfaction scores with plasma protease C1-inhibitor therapy

9.1 United States (US) Plasma Protease C1-Inhibitor Market Opportunity Assessment, By End-user, 2021 & 2031F

9.2 United States (US) Plasma Protease C1-Inhibitor Market Opportunity Assessment, By Product, 2021 & 2031F

10.1 United States (US) Plasma Protease C1-Inhibitor Market Revenue Share, By Companies, 2024

10.2 United States (US) Plasma Protease C1-Inhibitor Market Competitive Benchmarking, By Operating and Technical Parameters